General Information of the Compound
| Compound ID |
CP0451663
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[5-cyano-4-(2-methoxyethoxy)pyridin-2-yl]-6-[[(4S)-4-(dimethylamino)-2-oxopyrrolidin-1-yl]methyl]-7-formyl-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
Show/Hide
|
||||||||||||||||||
| Formula |
C26H31N7O5
|
||||||||||||||||||
| Molecular Weight |
521.578
|
||||||||||||||||||
| Canonical SMILES |
COCCOc1cc(NC(=O)N2CCCc3cc(CN4C[C@H](CC4=O)N(C)C)c(C=O)nc23)ncc1C#N
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H31N7O5/c1-31(2)20-10-24(35)32(15-20)14-18-9-17-5-4-6-33(25(17)29-21(18)16-34)26(36)30-23-11-22(38-8-7-37-3)19(12-27)13-28-23/h9,11,13,16,20H,4-8,10,14-15H2,1-3H3,(H,28,30,36)/t20-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
LWBSWJUHXCHFLP-FQEVSTJZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01343, Fibroblast growth factor receptor 4
Protein ID: PT07029, Fibroblast growth factor receptor 4